McNamara Robert 4

What Happened
Robert McNamara, a director of AVITA Medical, received equity awards reported on Form 4. The filing shows 22,214 restricted stock units (RSUs) and a grant of 16,133 stock options. No cash was paid to receive these grants; the option exercise price is $3.77 per share (the Nasdaq closing price on the grant date).

Key Details

• Transaction dates: grant date listed as January 20, 2026; these awards were subject to and received stockholder approval on June 3, 2026. Form 4 filed June 4, 2026.
• RSUs: 22,214 RSUs — each RSU represents a contingent right to one share; vesting occurs 12 months after the January 20, 2026 grant date (i.e., Jan 20, 2027). (Footnote F1)
• Options: 16,133 options granted to acquire 16,133 shares at $3.77 per share (grant recorded as a derivative award, not an exercise). (Footnote F3)
• Cash/consideration: Filing shows $0 paid at grant (awards issued, not purchased or exercised).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Includes unvested RSUs (Footnote F2).
• Timeliness: awards were originally granted Jan 20, 2026 but were contingent on shareholder approval obtained June 3, 2026; the Form 4 was filed the following day.

Context
These entries are awards (grant of RSUs and options), not open-market purchases or exercises. RSUs convert to actual shares only upon vesting (here, 12 months from the grant date), and options give the right to buy shares at $3.77 per share in the future if the holder exercises them. Awards approved by stockholders are routine compensation for directors and do not, by themselves, indicate immediate buying or selling of shares.